MAXCYTE INC. - COMMON
3.8800
08-十月-24 15:59:58
15 分钟延时
股票
+0.1000
+2.65%
今日范围
3.7500 - 3.8900
ISIN
N/A
来源
NASDAQ
-
MaxCyte to Participate in Two Upcoming Investor Conferences
06 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
04 10月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
06 9月 2023 08:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Baird Global Healthcare Conference
05 9月 2023 08:05:00 条件 Nasdaq GlobeNewswire
-
09 8月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
01 8月 2023 08:05:51 条件 Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2023 Financial Results on August 9, 2023
13 7月 2023 08:05:00 条件 Nasdaq GlobeNewswire
-
10 7月 2023 08:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with Lyell Immunopharma
06 7月 2023 08:05:05 条件 Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
01 6月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Guidance
10 5月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
04 5月 2023 08:05:53 条件 Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2023 Financial Results on May 10, 2023
12 4月 2023 16:05:30 条件 Nasdaq GlobeNewswire
-
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
27 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results
15 3月 2023 16:05:23 条件 Nasdaq GlobeNewswire
-
08 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
06 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
01 2月 2023 16:05:53 条件 Nasdaq GlobeNewswire
-
03 1月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
05 12月 2022 02:00:00 条件 Nasdaq GlobeNewswire